AU2002216214A1 - Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents - Google Patents
Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agentsInfo
- Publication number
- AU2002216214A1 AU2002216214A1 AU2002216214A AU1621402A AU2002216214A1 AU 2002216214 A1 AU2002216214 A1 AU 2002216214A1 AU 2002216214 A AU2002216214 A AU 2002216214A AU 1621402 A AU1621402 A AU 1621402A AU 2002216214 A1 AU2002216214 A1 AU 2002216214A1
- Authority
- AU
- Australia
- Prior art keywords
- piperazine
- quinolines
- substituted
- antibacterial agents
- containing moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Piperazine derivatives, containing a quinoline analog moiety, of formula (I) and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammal, particularly in man.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0031086.2A GB0031086D0 (en) | 2000-12-20 | 2000-12-20 | Medicaments |
GB0031086 | 2000-12-20 | ||
PCT/GB2001/005661 WO2002050040A1 (en) | 2000-12-20 | 2001-12-19 | Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002216214A1 true AU2002216214A1 (en) | 2002-07-01 |
Family
ID=9905479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216214A Abandoned AU2002216214A1 (en) | 2000-12-20 | 2001-12-19 | Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040077656A1 (en) |
EP (1) | EP1343765B1 (en) |
JP (1) | JP2004518660A (en) |
AT (1) | ATE346046T1 (en) |
AU (1) | AU2002216214A1 (en) |
DE (1) | DE60124761T2 (en) |
ES (1) | ES2276744T3 (en) |
GB (1) | GB0031086D0 (en) |
WO (1) | WO2002050040A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6803369B1 (en) | 2000-07-25 | 2004-10-12 | Smithkline Beecham Corporation | Compounds and methods for the treatment of neoplastic disease |
BR0112750A (en) | 2000-07-26 | 2003-09-09 | Smithkline Beecham Plc | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
DE60119939T2 (en) * | 2000-09-21 | 2006-11-30 | Smithkline Beecham P.L.C., Brentford | CHINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS |
GB0031088D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
TW200406410A (en) | 2002-01-29 | 2004-05-01 | Glaxo Group Ltd | Compounds |
AU2003239302A1 (en) * | 2002-01-29 | 2003-09-02 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
AR040335A1 (en) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | CYCLLOHEXAN OR CYCLHEXENE COMPOUND, USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE AND INTERMEDIATE COMPOUNDS OF UTILITY TO PREPARE SUCH COMPOUND |
TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
EP2239260A1 (en) | 2002-10-10 | 2010-10-13 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Novel compounds with antibacterial activity |
EP1560821B8 (en) * | 2002-11-05 | 2010-05-19 | Glaxo Group Limited | Antibacterial agents |
DE60334016D1 (en) | 2002-11-05 | 2010-10-14 | Glaxo Group Ltd | ANTIBACTERIAL AGENTS |
AU2003294565A1 (en) | 2002-12-04 | 2004-06-23 | Glaxo Group Limited | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
JP2008528586A (en) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | Antibacterial agent |
JP2008528587A (en) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | Antibacterial agent |
US7511035B2 (en) | 2005-01-25 | 2009-03-31 | Glaxo Group Limited | Antibacterial agents |
JP2008528588A (en) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | Antibacterial agent |
JP2008528598A (en) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | Antibacterial agent |
JP5023054B2 (en) | 2005-03-31 | 2012-09-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Bicyclic pyrazole compounds as antibacterial agents |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
ES2376488T3 (en) | 2006-01-26 | 2012-03-14 | Actelion Pharmaceuticals Ltd. | TETRAHYDROPIRAN ANTIBIOTICS. |
CA2643983A1 (en) * | 2006-02-21 | 2007-08-30 | Amgen, Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
EP1991531A1 (en) * | 2006-02-28 | 2008-11-19 | Amgen Inc. | Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors |
JP2009529060A (en) * | 2006-03-08 | 2009-08-13 | アムゲン インコーポレイティッド | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
EP2007377A4 (en) | 2006-04-06 | 2011-08-17 | Glaxo Group Ltd | Antibacterial agents |
CL2008001003A1 (en) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION. |
CL2008001002A1 (en) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION. |
EP2245028B1 (en) * | 2007-12-18 | 2012-02-22 | Actelion Pharmaceuticals Ltd. | 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
TWI429643B (en) | 2008-02-22 | 2014-03-11 | Actelion Pharmaceuticals Ltd | Oxazolidinone derivatives |
AU2009302007B2 (en) * | 2008-10-10 | 2015-01-15 | Actelion Pharmaceuticals Ltd | Oxazolidinyl antibiotics |
TW201309689A (en) | 2011-02-07 | 2013-03-01 | Daiichi Sankyo Co Ltd | Amino group-containing pyrrolidinone derivatives |
AR089929A1 (en) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | PROCESS TO MANUFACTURE A NAFTIRIDINE DERIVATIVE |
WO2014024056A1 (en) | 2012-08-06 | 2014-02-13 | Daiichi Sankyo Company, Limited | Pyrrolidine derivatives with antibacterial properties |
US11884647B2 (en) | 2019-10-18 | 2024-01-30 | The Regents Of The University Of California | Compounds and methods for targeting pathogenic blood vessels |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR86513E (en) * | 1963-03-25 | 1966-02-25 | Rhone Poulenc Sa | New quinoline derivatives and their preparation |
US5721237A (en) * | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
EP0541486A1 (en) * | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclic conjugates |
JP3474941B2 (en) * | 1994-09-19 | 2003-12-08 | ポーラ化成工業株式会社 | Drug resistance overcomer |
JP2000500467A (en) * | 1995-11-13 | 2000-01-18 | スミスクライン・ビーチャム・コーポレイション | Blood regulatory compounds |
US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
ES2201674T3 (en) * | 1998-01-26 | 2004-03-16 | Smithkline Beecham Plc | DERIVATIVES OF QUINOLINA WITH ANTIBACTERIAL PROPERTIES. |
GB9822440D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9822450D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
EP1144404A1 (en) * | 1999-01-20 | 2001-10-17 | Smithkline Beecham Plc | Piperidinylquinolines as protein tyrosine kinase inhibitors |
GB9914486D0 (en) * | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
GB9917406D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
GB9917408D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
US6403610B1 (en) * | 1999-09-17 | 2002-06-11 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
FR2798656B1 (en) * | 1999-09-17 | 2004-12-17 | Aventis Pharma Sa | DERIVATIVES OF QUINOLYL PROPYL PIPERIDINE, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
US6803369B1 (en) * | 2000-07-25 | 2004-10-12 | Smithkline Beecham Corporation | Compounds and methods for the treatment of neoplastic disease |
BR0112750A (en) * | 2000-07-26 | 2003-09-09 | Smithkline Beecham Plc | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
DE60119939T2 (en) * | 2000-09-21 | 2006-11-30 | Smithkline Beecham P.L.C., Brentford | CHINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS |
US6603005B2 (en) * | 2000-11-15 | 2003-08-05 | Aventis Pharma S.A. | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
GB0031088D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
US6602884B2 (en) * | 2001-03-13 | 2003-08-05 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
US20030203917A1 (en) * | 2001-07-25 | 2003-10-30 | Smithkline Beecham Corporation And Smithkline Beecham P.L.C. | Compounds and methods for the treatment of neoplastic disease |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
-
2000
- 2000-12-20 GB GBGB0031086.2A patent/GB0031086D0/en not_active Ceased
-
2001
- 2001-12-19 JP JP2002551537A patent/JP2004518660A/en active Pending
- 2001-12-19 EP EP01271361A patent/EP1343765B1/en not_active Expired - Lifetime
- 2001-12-19 US US10/450,892 patent/US20040077656A1/en not_active Abandoned
- 2001-12-19 WO PCT/GB2001/005661 patent/WO2002050040A1/en active IP Right Grant
- 2001-12-19 DE DE60124761T patent/DE60124761T2/en not_active Expired - Fee Related
- 2001-12-19 ES ES01271361T patent/ES2276744T3/en not_active Expired - Lifetime
- 2001-12-19 AT AT01271361T patent/ATE346046T1/en not_active IP Right Cessation
- 2001-12-19 AU AU2002216214A patent/AU2002216214A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002050040A1 (en) | 2002-06-27 |
ATE346046T1 (en) | 2006-12-15 |
DE60124761D1 (en) | 2007-01-04 |
EP1343765B1 (en) | 2006-11-22 |
US20040077656A1 (en) | 2004-04-22 |
DE60124761T2 (en) | 2007-09-13 |
ES2276744T3 (en) | 2007-07-01 |
GB0031086D0 (en) | 2001-01-31 |
JP2004518660A (en) | 2004-06-24 |
EP1343765A1 (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002216214A1 (en) | Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents | |
ATE294792T1 (en) | NAPHTHYRIDINES AND THEIR AZAISOSTERENE ANALOGAS AS ANTIBACTERIAL AGENTS | |
AU6339599A (en) | Quinoline derivatives and their use as antibacterial agents | |
WO2002050061A8 (en) | Piperazine derivatives for treatment of bacterial infections | |
WO2003010138A3 (en) | Piperidine derivatives as antibacterial agents | |
AU5986200A (en) | Compounds | |
AU2002218192A1 (en) | Quinoline derivatives as antibacterials | |
BG106524A (en) | Piperidine quinolyl propyl derivatives and their use as antibacterial means | |
MY138797A (en) | Bacterial gyrase inhibitors and uses thereof | |
NO20053046L (en) | 4-oxo-1 (3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors). | |
MXPA03000708A (en) | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity. | |
ATE255104T1 (en) | QUINOLINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL ACTIVES | |
JO2311B1 (en) | Alkyne-aryl phosphodiesterase-4 inhibitors | |
ATE264852T1 (en) | QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS | |
DE60221969D1 (en) | BY PIPERIDINE-CONTAINING GROUPS SUBSTITUTED CHINOLINES AND THE NITROGEN-DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
BR9909994A (en) | Quinolines used as mrs and bactericide inhibitors | |
PL358666A1 (en) | 2-hydroxy-mutilin carbamate derivatives for antibacterial use | |
PE20030061A1 (en) | 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS | |
YU66700A (en) | Carbapenem derivatives, utilization thereof and intermediate compounds of the same |